News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Changing treatment news

Show

From To
Side-effects
Switch from efavirenz to raltegravir improves mood and lipid profiles

Switching from efavirenz (Sustiva) to raltegravir (Isentress) is associated with improvements in mood and lipid profiles, Swiss investigators report in the online edition of AIDS. Efavirenz is a

Published
07 June 2011
By
Michael Carter
Changing treatment
International team to investigate second-line HIV therapy in Africa

The largest clinical trial to investigate treatment options for individuals whose first combination of anti-HIV medicines is no longer working has been announced following the recruitment of 1,200 HIV-positive individuals from across five African

Published
18 May 2011
From
University College Dublin
Starting treatment
HIV drug prescribing in London to change from this month

London HIV patients will start treatment with Kivexa (abacavir and 3TC) rather than tenofovir and FTC for at least the next two years in a bid

Published
06 April 2011
By
Gus Cairns
UK health services
HIV drug prescribing in London: changes from this month

From April 2011, the preferred first- and second-line drug regimens for HIV-positive people in London are changing. The change in prescribing practice will not initially affect people

Published
01 April 2011
From
HIV treatment update
Changing treatment
Switch to maraviroc possible after co-receptor testing on stored blood samples

A switch to maraviroc due to poor tolerance of other antiretroviral drugs can be accomplished after carrying out a tropism test on pre-treatment stored blood

Published
15 February 2011
By
Michael Carter
Treatment-experienced people
Drug Resistance Shouldn’t Preclude Using NRTIs in an HIV Salvage Regimen

People with heavily drug-resistant HIV benefit from adding two nucleoside reverse transcriptase inhibitors (NRTIs) to a regimen that contains Isentress (raltegravir), even if their virus is partially or fully resistant to the NRTIs. These data were published online January 28 in the Journal of Acquired Immune Deficiency Syndromes.

Published
02 February 2011
From
AIDSMeds
Free online tool may help doctors make treatment decisions for HIV-positive patients with drug resistance

UK investigators have developed an online resource that can help doctors select the most effective combination of anti-HIV drugs for patients with extensive experience of antiretroviral therapy.

Published
20 January 2011
By
Michael Carter
Epidemiology
India: Despite Supreme Court breather, HIV patients will have to wait for treatment

Despite the Supreme Court’s directive last month to make second- line HIV/AIDS treatment available free of cost to all those who need it, patients in non-metros will have to wait till March.

Published
12 January 2011
From
DNA
India
Post SC order, HIV patients flood JJ for second-line care

The recent Supreme Court (SC) directive to allow patients taking second- line drugs against HIV/AIDS to shift from private hospitals to government-run ones has brought out a startling fact. It has now come to light that many HIV patients were put on the very expensive second-line drugs by unscrupulous private doctors even without putting them in the first-line.

Published
09 January 2011
From
Mumbai Mirror
Changing treatment
Abbott's HIV drug patent plea rejected for lack of novelty

India has rejected an HIV drug patent application filed by US-based Abbott Laboratories, as it lacked novelty under domestic laws. The denial of patent will help domestic drug-makers to produce and market low-cost versions of this drug in the developing

Published
03 January 2011
From
Business-Standard
← Prev1...23456...21Next →

Filter by country